Cargando…
Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
BACKGROUND: Cervical cancer is the fourth most frequent gynecological malignancy across the world. Immunotherapies have proved to improve prognosis of cervical cancer. However, few studies on immune-related prognostic signature had been reported in cervical cancer. METHODS: Raw data and clinical inf...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148954/ https://www.ncbi.nlm.nih.gov/pubmed/35651784 http://dx.doi.org/10.3389/fonc.2022.861392 |